Literature DB >> 8915612

Ageing and amyloid fibrillogenesis: lessons from apolipoprotein AI, transthyretin and islet amyloid polypeptide.

P Westermark1, K Sletten, K H Johnson.   

Abstract

The age-associated (or senile) amyloidoses encompass a heterogeneous group of systemic or localized forms of amyloidosis. In this paper we present an overview of three age-associated amyloid forms derived from transthyretin, apolipoprotein AI and islet amyloid polypeptide. Mutations in the respective genes give rise to transthyretin and apolipoprotein AI forms of familial amyloidosis while senile forms of amyloid are associated with the wild-type proteins. Different mechanisms are probably of importance in the fibrillogenesis associated with these three amyloid types. It is also possible that different amyloidogenic pathways exist for a single amyloidogenic protein. Thus, limited proteolysis may be necessary in the fibrillogenesis in senile transthyretin amyloidosis but not in most familial transthyretin amyloidoses. Other factors in the pathogenesis of amyloidosis such as local concentration, nidus formation and glycation are also discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915612     DOI: 10.1002/9780470514924.ch13

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  5 in total

1.  Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I.

Authors:  Yuan Qi Wong; Katrina J Binger; Geoffrey J Howlett; Michael D W Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

2.  Early pathogenesis of cardiac amyloid deposition in senile systemic amyloidosis: close relationship between amyloid deposits and the basement membranes of myocardial cells.

Authors:  Motoji Sawabe; Akihiko Hamamatsu; Tateki Ito; Tomio Arai; Kumiko Ishikawa; Kouji Chida; Naotaka Izumiyama; Naoko Honma; Kaiyo Takubo; Masamitsu Nakazato
Journal:  Virchows Arch       Date:  2003-02-26       Impact factor: 4.064

Review 3.  Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis.

Authors:  Teresa Coelho; Giampaolo Merlini; Christine E Bulawa; James A Fleming; Daniel P Judge; Jeffery W Kelly; Mathew S Maurer; Violaine Planté-Bordeneuve; Richard Labaudinière; Rajiv Mundayat; Steve Riley; Ilise Lombardo; Pedro Huertas
Journal:  Neurol Ther       Date:  2016-02-19

4.  Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis.

Authors:  P Patrizia Mangione; Riccardo Porcari; Julian D Gillmore; Piero Pucci; Maria Monti; Mattia Porcari; Sofia Giorgetti; Loredana Marchese; Sara Raimondi; Louise C Serpell; Wenjie Chen; Annalisa Relini; Julien Marcoux; Innes R Clatworthy; Graham W Taylor; Glenys A Tennent; Carol V Robinson; Philip N Hawkins; Monica Stoppini; Stephen P Wood; Mark B Pepys; Vittorio Bellotti
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

5.  A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis.

Authors:  Julien Marcoux; P Patrizia Mangione; Riccardo Porcari; Matteo T Degiacomi; Guglielmo Verona; Graham W Taylor; Sofia Giorgetti; Sara Raimondi; Sarah Sanglier-Cianférani; Justin L P Benesch; Ciro Cecconi; Mohsin M Naqvi; Julian D Gillmore; Philip N Hawkins; Monica Stoppini; Carol V Robinson; Mark B Pepys; Vittorio Bellotti
Journal:  EMBO Mol Med       Date:  2015-10       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.